Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Œsophage » Néoplasie

16. Septembre 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Troubles de la motilité

Écriture:

Page 1 de 1984


	Articles 1 - 20 / 39669

	Case Report: Small bowel metastasis from esophageal squamous cell carcinoma: a case series and systematic review of clinical characteristics, tropism, and survival outcomes. Front Immunol Zhou M, Liu Y, Huang H, Chen X, Huang Q, Huang S, Yan Z, Chen Y, Lin J, Huang J, Xie G, Hou Y, Huang Y. PMID: 42741216 [PubMed - indexed for MEDLINE]
	Dynamic survival prediction using longitudinal AGR in unresectable locally advanced esophageal squamous cell carcinoma. Front Immunol Du F, Deng W, Xiao Y, Yu R, Jia J. PMID: 42740913 [PubMed - indexed for MEDLINE]
	Differential Cancer Risks and Noninvasive Predictors in MASLD, MetALD, and ALD: A Longitudinal Analysis. Gut Liver Park H, Lee JY, Koo JE, Lee JS, Park S, Park HW, Chang HS, Kim HK, Choe J, Shim JH. PMID: 42740439 [PubMed - indexed for MEDLINE]
	Sintilimab plus Bevacizumab biosimilar IBI305 and chemotherapy as a first-line treatment in advanced gastric or gastroesophageal junction adenocarcinoma (SBAGA): a single-arm, phase Ib/II study. Nat Commun Cheng M, Zhang P, Hu Q, Zhou J, Dai R, Li W, Wei J, Xu M, Lei Y, Li X, Zheng X, Huang Q, Li Z, Zhang B, Zhuang W, Chen Z, Chen X, Shen C, Zhang W, Liu K, Zhao L, Yin X, Peng B, Cai Z, Yin Y, Chen J, Liu C, Kang D, Wang M, Gou H, Yang K, Hu J, Bi F, Liu M. PMID: 42736273 [PubMed - indexed for MEDLINE]
	Impact of Upper Mediastinal Anatomy and Anastomotic Position on Anastomotic Leakage After Transcervical-Hiatal Subtotal Esophagectomy With Posterior Mediastinal Reconstruction. Asian J Endosc Surg Kuroda A, Yajima S, Asaoka R, Sugawara K, Higashizono K, Okamoto A, Oya S, Miwa Y, Yagi K, Baba Y. PMID: 42735898 [PubMed - indexed for MEDLINE]
	Sentinel Node Navigation Surgery for Upper Gastrointestinal Malignancies: Current Status, Clinical Significance, and Future Perspectives. Magy Onkol Hiramatsu Y, Booka E, Kikuchi H, Takeuchi H. PMID: 42731004 [PubMed - indexed for MEDLINE]
	Development and internal validation of a prediction model for early anastomotic leak after minimally invasive esophagectomy: a prospective cohort study. Ann Med Feng ZB, Ren XF, Xue MH, Bao PL, Xu H, Gao F, Ma Y, Zhao JB, Bai YQ. PMID: 42730478 [PubMed - indexed for MEDLINE]
	Efficacy and safety of liposomal irinotecan plus nimotuzumab in immune checkpoint inhibitor-refractory recurrent or metastatic nasopharyngeal carcinoma: a single-arm, open-label, phase II trial. EClinicalMedicine He S, Bei WX, Lu N, Zhao ZY, Ye Y, Chen C, Tang L, Liu L, Lv S, Xiang YQ, Wang L. PMID: 42729623 [PubMed]
	Risk factors for postoperative intensive care unit admission after minimally invasive esophagectomy following neoadjuvant chemoimmunotherapy in patients with esophageal squamous cell carcinoma: a retrospective cohort study. Front Oncol Chen Z, Liu ZJ, Liu QX, Chen PF, Jiang YC. PMID: 42729186 [PubMed]
	Integrative Analysis of IGFL2â€‘AS1 and BRCA1 Expression in Esophageal Cancer: An Experimental and Bioinformaticsâ€‘Based Study. Iran Biomed J Marhamati S, Jalili H, Ziamajidi N, Bahmani M, Abbasalipourkabir R. PMID: 42728357 [PubMed - as supplied by publisher]
	International case-control study of DNA methylation biomarkers for the minimally invasive diagnosis of esophageal squamous cell carcinoma. Clin Transl Gastroenterol Cheng Y, Banavar A, Ma K, Obwoya PS, Luhuti K, Tuhumwire C, Gheshlaghi S, Fan K, Yang Y, Hsieh K, Hasnain AC, Ahmed Y, Ngamruenghphong S, Khashab M, Singh V, Hamilton JP, Shin EJ, Akarapipad P, Mushi B, Selekwa M, Mmbage E, Ringo Y, Tumuhimbise C, Tusiime F, Van Loon K, Byaruhanga E, Wang TH, Okello S, Buckle G, Meltzer SJ. PMID: 42727930 [PubMed - as supplied by publisher]
	Patient experiences and decision-making priorities in early esophageal cancer: a qualitative interview study. Dis Esophagus Cole K, Bhandari P, White M, Underwood T, Markar S, Pucher P, Association of Upper GI Surgery GB&I (AUGIS). PMID: 42726912 [PubMed - indexed for MEDLINE]
	A neutrophil-to-lymphocyte ratio-centered machine learning model for predicting immunotherapy response in esophageal squamous cell carcinoma patients. J Thorac Dis Li T, Zhang X, Chen J, Liu Z, Xu S, Jiang L, Wei Z, Guo W, He Y, Wu W, Yang L, Wu Y. PMID: 42724642 [PubMed]
	Identification of recurrence risk factors and development of personalized follow-up strategies for esophageal squamous cell carcinoma patients after neoadjuvant therapy and surgery: a retrospective cohort study. J Thorac Dis Cai Y, Wei N, Cai X, Ding J, Teng C, Chen L. PMID: 42724562 [PubMed]
	Prognostic significance of recurrent laryngeal nerve lymph node dissection in esophageal squamous cell carcinoma: a systematic review and meta-analysis. J Thorac Dis Xu S, Ni Y, Duan S, Chen Y. PMID: 42724238 [PubMed]
	Use of volumetric analysis to predict pathologic response in esophageal cancer: a single-institution cohort study. J Thorac Dis Klipsch E, Hardin S, Duckworth K, Sokevitz K, Rodgers J, Mann D, Gibney BC, Engelhardt KE, Baruah D, Bostock IC. PMID: 42724228 [PubMed]
	Impact of Dyslipidemia on Clinical Outcomes Among Cancer Patients Treated With Immune Checkpoint Inhibitors. Cancer Med Liang Y, Maeda O, Ishida S, Zennami K, Kimura T, Inoue S, Sano T, Sano Y, Naito Y, Miyata K, Shimizu D, Nishida K, Chrétien B, Kanda M, Akamatsu S, Ando Y. PMID: 42723154 [PubMed - indexed for MEDLINE]
	Artificial intelligence-based virtual iodine staining model for esophageal squamous cell carcinoma: a multicenter proof-of-concept study. Surg Endosc Zeng X, Cai L, Xiao L, Chen Z, Yin X, Yang D, Ou Y, Cheng Q, Zheng Y, Fu Z, Xiang S, Liao J, Gong X, Jiang W, Yuan X. PMID: 42722908 [PubMed - as supplied by publisher]
	Trastuzumab Deruxtecan (T-DXd) in HER2-Positive Advanced Gastric and Gastroesophageal Junction Cancer: Evidence, Sequencing, Patient Selection, and Clinical Decision-Making. J Gastrointest Cancer Sagawa T, Hirakawa M, Nagashima H, Fujikawa K. PMID: 42720868 [PubMed - indexed for MEDLINE]
	Comparison of in-field secondary cancer risk based on therapeutic proton dose between proton arc therapy and intensity-modulated proton therapy in lung cancer patients. J Appl Clin Med Phys Xu Y, Chen W, Wu J, Guo H, Zeng F, Zhang T, Yang F, Huang X, Zhang D, Wang X. PMID: 42717736 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 39669

Page 1 de 1984



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité